Clinical Trial Results: Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial results on cardiac uptake of 18F Florbetapir in patients undergoing chemotherapy for cardiac amyloidosis. The study is terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Drugs mentioned

• 18F Florbetapir

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Cardiac Amyloidosis | Phase 4 | Status: TERMINATED | Results posted: 2026-07-16